Peer-to-Peer Support Program in Improving Quality of Life Outcomes in Patients With Gynecologic Cancer and Their Caregivers
NCT02412124 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3
Last updated 2018-05-11
Summary
This pilot clinical trial studies a peer-to-peer support program in improving quality of life outcomes in patients with gynecologic cancer and their caregivers. Peer-to-peer support and mentoring may help improve quality of life and reduce symptoms of distress in gynecologic cancer patients and their families.
Conditions
- Cervical Carcinoma
- Ovarian Carcinoma
- Uterine Corpus Cancer
- Vaginal Carcinoma
- Vulvar Carcinoma
Interventions
- PROCEDURE
-
Supportive Care
Complete W2W mentoring program
- OTHER
-
Quality-of-Life Assessment
Complete the FACT-G
- OTHER
-
Questionnaire Administration
Complete the W2W Patient Survey
Sponsors & Collaborators
-
National Cancer Institute (NCI)
collaborator NIH -
City of Hope Medical Center
lead OTHER
Principal Investigators
-
Thanh Dellinger, MD · City of Hope Medical Center
Study Design
- Allocation
- NA
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 19 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2015-07-31
- Primary Completion
- 2018-04-30
- Completion
- 2018-04-30
Countries
- United States
Study Locations
More Related Trials
-
Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
NCT00719303 ·Status: UNKNOWN ·Phase: PHASE3
-
Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endometrial Cancer
NCT00942357 ·Status: UNKNOWN ·Phase: PHASE3
-
Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Ovarian Epithelial Cancer
NCT00005612 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
NCT03042897 ·Status: WITHDRAWN ·Phase: NA
-
Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Persistent Epithelial Ovarian Cancer, Fallopian Tube, or Primary Peritoneal Cancer
NCT00003064 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Docetaxel, Trabectedin, and G-CSF or Pegfilgrastim in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer
NCT00569673 ·Status: COMPLETED ·Phase: PHASE2
-
Letrozole With or Without Paclitaxel and Carboplatin in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
NCT04095364 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Quality-of-Life Assessment in Patients With Ovarian Cancer
NCT00003772 ·Status: COMPLETED
-
Palliative Care in Improving Quality of Life and Symptoms in Patients With Stage III-IV Pancreatic or Ovarian Cancer
NCT01927393 ·Status: WITHDRAWN ·Phase: NA
-
Impact of Adjuvant Chemotherapy on the Quality of Life of Patients Treated for Stage II / III Endometrial Cancer
NCT03466788 ·Status: COMPLETED ·Phase: NA
-
A Study of Short-Course Radiation Therapy With Chemotherapy in People With Endometrial Cancer
NCT05691010 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Palliative Care in Improving Quality of Life in Patients With High Risk Primary or Recurrent Gynecologic Malignancies
NCT02578888 ·Status: COMPLETED ·Phase: NA
-
Paclitaxel and Carboplatin With or Without Metformin Hydrochloride in Treating Patients With Stage III, IV, or Recurrent Endometrial Cancer
NCT02065687 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Chemotherapy Toxicity On Quality of Life in Older Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer
NCT01366183 ·Status: UNKNOWN
-
Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy
NCT01080521 ·Status: COMPLETED
-
Carboplatin, Paclitaxel, and Pegfilgrastim in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, Primary Peritoneal, or Carcinosarcoma Cancer
NCT00352300 ·Status: COMPLETED ·Phase: PHASE1
-
Combination Chemotherapy in Treating Patients With Advanced Ovarian Epithelial Cancer
NCT00005051 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
NCT00003944 ·Status: COMPLETED ·Phase: PHASE2
-
Hyperthermic Intraperitoneal Chemotherapy With Cisplatin During Surgery or Cisplatin Before Surgery for the Treatment of Stage III or IV Ovarian, Fallopian Tube or Peritoneal Cancer
NCT05415709 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Timing of Surgery and Chemotherapy in Treating Patients With Newly Diagnosed Advanced Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer
NCT00075712 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Talazoparib and Radiation Therapy in Treating Patients With Locally Recurrent Gynecologic Cancers
NCT03968406 ·Status: RECRUITING ·Phase: PHASE1
-
Palliative Care During Intraperitoneal Chemotherapy in Patients With Ovarian Cancer
NCT00804258 ·Status: COMPLETED
-
Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III Ovarian Cancer
NCT00004221 ·Status: TERMINATED ·Phase: PHASE2
-
Sexual Functioning After Primary Treatment of Ovarian Cancer
NCT00596544 ·Status: TERMINATED
-
Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed, Persistent or Recurrent Uterine, Ovarian, Fallopian Tube, or Peritoneal Cavity Cancer
NCT00954174 ·Status: UNKNOWN ·Phase: PHASE3